Glow Blend (GHK-Cu, BPC-157, TB-500) typically comes in a 35 mg vial
That happens with fighters, too
This dose was chosen rather than the 3 mg/kg starting dose used in rheumatoid arthritis (RA) as it was felt that PsA, a spondyloarthropathy, might respond better to the dosing used in irritable bowel disease (IBD), which shares some genetic and possible pathophysiologic characteristics
BPC-157 has attracted significant scientific attention due to its apparent multi-tissue activity in research models, with studies spanning tendon, muscle, bone, nerve, and gastrointestinal tissue
You May Also Like $59.99 $79.99 BPC-157 Regenerative ResearchThis product has multiple variants
Verified Customer IMPORTANT NOTICE These products are intended strictly for laboratory and research purposes only